Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets

Table 2

System suitability parameters.

Parameter	MET	GLB	Acceptable limits
Retention time (RT)	2.206 ± 0.046	3.828 ± 0.058
	RSD = 0.002	RSD = 0.003	RSD<1%
Theoretical plates (N)	2,300	4,356	N > 2000
Tailing factor (T)	1.65 + 0.02	1.134 + 0.04	T < 2